Trial
NCT01562132
Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); Kenya Medical Research Institute; Bausch Health Americas, Inc.; University of Nairobi
Condition
Cryptococcal Infection Disseminated
Intervention
Flucytosine and fluconazole
Why stopped
Stopped in accordance with pre-specified stopping rules for poor recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-29